![]() 7-Ethyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine structure
|
Common Name | 7-Ethyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine | ||
---|---|---|---|---|
CAS Number | 2389988-43-4 | Molecular Weight | 327.29 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C12H17N5O6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of 7-Ethyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine7-Ethyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
Name | 7-Ethyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine |
---|
Description | 7-Ethyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C12H17N5O6 |
---|---|
Molecular Weight | 327.29 |